Author archive for Admin Isofol

  • Interviewed made by Redeye

    Redeye has interviewed Ulf Jungnelius, CEO of Isofol, regarding the announcement that the AGENT study will be completed with 440…

    by
  • The abstract for AACR 2021 has been published

    The approved abstract for the congress American Association for Cancer Research (AACR) 2021 has been published on their website. The…

    by
  • Isofol announces that an abstract has been approved for AACR in April 2021

    Isofol announces that an abstract has been approved for presentation at the virtual American Association for Cancer Research (AACR) Congress…

    by
  • Isofol to present gene expression results from the completed Phase I/IIa ISO-CC-005 study today at ASCO-GI 2021 and updates of the timing of the interim analysis in the AGENT study

    GOTHENBURG, Sweden, January 15, 2021 - Isofol Medical AB (publ) (“Isofol”), (Nasdaq First North Premier Growth Market: ISOFOL) announces that…

    by
  • Isofol reaches 440 patients in global Phase III AGENT study

    GOTHENBURG, Sweden, December 9, 2020 - Isofol Medical AB (publ) (“Isofol”), (Nasdaq First North Premier Growth Market: ISOFOL) announces that…

    by
  • Isofol presents an abstract at ASCO GI in January 2021

    Isofol announces that an abstract, including arfolitixorin in the ISO-CC-005 study, has been accepted to be presented at ASCO GI…

    by
  • Invitation to a conference call and webcast by Isofol in connection with the entered license agreement for Paladin Labs Inc. to commercialize arfolitixorin in Canada

    GOTHENBURG, Sweden, November 2, 2020 - Isofol Medical AB (publ) (“Isofol”), (Nasdaq First North Premier Growth Market: ISOFOL) has today…

    by
  • A milestone is reached with the inclusion of 330 patients in the AGENT-study – opening up for the interim analysis

    GOTHENBURG, Sweden, July 21, 2020 – Isofol Medical AB (Nasdaq First North Premier Growth Market: ISOFOL), today announced that 330 patients…

    by
  • Arfolitixorin is presented as one of the most promising pipeline drugs in the new CRC report by Global Data

    Global Data recently published an outlook for the CRC market between 2018 and 2028 for the 8 major markets (8MM),…

    by
  • Empowered patient podcast

    Our CEO, Dr. Ulf Jungnelius, was featured on Karen Jagoda’s empowered patient podcast to discuss colorectal cancer and how our…

    by